Search

everythinglearnresearchcommunity

for

Search:↓

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

Older women's scalp cells show changes that could contribute to hair thinning.

Minoxidil is effective for hair growth and safe for long-term use.

More men are getting cosmetic surgery, with nose jobs and hair transplants being popular, and choosing a qualified surgeon is important.

IGF-1R may play a role in female hair loss and could be a treatment target.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

New treatments for skin and hair repair show promise, but further improvements are needed.

Certain skin drugs and topical agents, including some natural extracts and fragrances, can cause allergic reactions. Some hair dyes and extensions, as well as minoxidil, a hair growth treatment, can also cause allergies. Botulinum toxin A can effectively reduce sweat but may have temporary side effects.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Australian fur seals' fur shows high levels of pollutants, which may be linked to hair loss in young female seals.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Trichoscopy helps diagnose and manage hair and scalp disorders in children.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.

Topical antiandrogens might treat skin issues like hair growth, balding, and acne, but finding effective treatments without side effects is challenging.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Panchkarma treatment can help manage symptoms of Systemic Lupus Erythematous.

Lupus can be a rare cause of high calcium levels in the blood.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Wnt ligand secretion by hair follicle cells is essential for hair growth and repair.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

The document suggests more research is needed to understand skin conditions related to toothpaste and other treatments.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.